Aldevron

Fargo, United States Founded: 1998 • Age: 28 yrs Acquired By Danaher
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
Request Access

About Aldevron

Aldevron is a company based in Fargo (United States) founded in 1998 was acquired by Danaher in June 2021.. The company has 747 employees as of December 31, 2022. Aldevron has completed 1 acquisition, including Genovac. Aldevron offers products and services including Plasmid DNA Manufacturing, mRNA Manufacturing, and Protein and Enzyme Manufacturing. Aldevron operates in a competitive market with competitors including Senti Biosciences, Poseida Therapeutics, KBI Biopharma, ADARx Pharmaceuticals and CRISPR Therapeutics, among others.

  • Headquarter Fargo, United States
  • Employees 747 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aldevron, Llc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Danaher

    & 3 more

  • Employee Count
    747

    as on Dec 31, 2022

  • Investments & Acquisitions
  • Acquired by
    Danaher

    & 1 more

    (Jun 17, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aldevron

Aldevron offers a comprehensive portfolio of products and services, including Plasmid DNA Manufacturing, mRNA Manufacturing, and Protein and Enzyme Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Produces high-quality DNA for research and clinical applications.

Offers scalable RNA production with encapsulation options.

Creates custom proteins for diagnostics and therapy uses.

People of Aldevron
Headcount 200-500
Employee Profiles 4
Employee Profiles
People
Keleigh Pearson
Assistant General Counsel - NABU

Unlock access to complete

Teams

Funding Insights of Aldevron

  • Total Funding
  • Total Rounds 4
  • Last Round
  • First Round

    (10 Aug 2007)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2017 Amount Private Equity Round - Aldevron Valuation TA
Sep, 2013 Amount Grant - Aldevron Valuation

investors

HHS
Feb, 2009 Amount Grant - Aldevron Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aldevron

Aldevron has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Danaher, EQT and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Multiple sectors are invested in by private equity firm TA.
Founded Year Domain Location
EQT is recognized as a global investment organization focused on value creation.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aldevron

Aldevron has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genovac. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Antibody discovery platforms and technologies are developed for protein targets.
1999
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Aldevron

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aldevron Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aldevron

Aldevron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Poseida Therapeutics, KBI Biopharma, ADARx Pharmaceuticals and CRISPR Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cell-based therapies for cancer treatment are developed.
domain founded_year HQ Location
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
domain founded_year HQ Location
Provider of protein formulation, process & cell line development, and cGMP services
domain founded_year HQ Location
Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts
domain founded_year HQ Location
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aldevron

Frequently Asked Questions about Aldevron

When was Aldevron founded?

Aldevron was founded in 1998 and raised its 1st funding round 9 years after it was founded.

Where is Aldevron located?

Aldevron is headquartered in Fargo, United States. It is registered at Fargo, North Dakota, United States.

How many employees does Aldevron have?

As of Dec 31, 2022, the latest employee count at Aldevron is 747.

What does Aldevron do?

Founded in 1998 and based in Fargo, United States, Aldevron operates in the biotechnology sector, focusing on nucleic acid and protein manufacturing. Plasmid DNA production has been completed for over 70,000 projects using proprietary methods, supporting research, preclinical, clinical, and diagnostic needs. Services include gene-to-protein manufacturing for custom enzymes, recombinant antibodies, and proteins, alongside antibody development through genetic, protein, and peptide immunization for reagents, diagnostics, and therapeutics.

Who are the top competitors of Aldevron?

Aldevron's top competitors include CRISPR Therapeutics, Senti Biosciences and KBI Biopharma.

What products or services does Aldevron offer?

Aldevron offers Plasmid DNA Manufacturing, mRNA Manufacturing, and Protein and Enzyme Manufacturing.

How many acquisitions has Aldevron made?

Aldevron has made 1 acquisition, including Genovac.

Who are Aldevron's investors?

Aldevron has 4 investors. Key investors include Danaher, EQT, HHS, and TA Associates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available